Issue 27
Get instant access to latest e-book

latest newsRead more...

25

Jul 2017

Samumed Receives Orphan Drug Designation from FDA for SM04646

Samumed announced that the US Food and Drug Administration FDA has granted SM a novel small molecule Wnt pathway inhibitor an Orphan Drug Designation ODD for IPF httpbitlygStpOf The FDAs decision to grant an ODD to SM for IPF is another important milestone in the…

25

Jul 2017

Seattle Genetics Announces Clinical Collaboration with Genentech

Seattle Genetics Inc a global biotechnology company today announced a clinical collaboration agreement with Genentech a member of the Roche Group for the evaluation of its investigational antibodydrug conjugate ADC SGNLIVA in combination with atezolizumab TECENTRIQ in patients with metastatic triplenegative breast cancer TNBC SGNLIVA…

24

Jul 2017

STA Signs Supply Agreement with TESARO

STA Pharmaceutical Co Ltd a WuXi AppTec subsidiary and the leading openaccess capability and technology platform for small molecule pharmaceutical development and manufacturing announces it signed a supply agreement with the oncologyfocused biopharmaceutical company TESARO Inc TESARO for certain starting and intermediate materials for ZEJULA…

press releasesRead more...

25

Jul 2017

Technology Innovation, the Key for Healthcare Delivery Excellence

Business Wire IndiaIcons of Healthcare Global Summit Awards The nd Icons of Healthcare Summit a pan Asia forum deliberating the challenges in healthcare delivery celebrating excellence by BERG Singapore was…

25

Jul 2017

Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

Johnson Johnson today announced encouraging firstinhuman clinical data for an investigational HIV vaccine regimen in development at its Janssen Pharmaceutical Companies In an oral presentation of the early stage Phase…

25

Jul 2017

DelMar Pharmaceuticals Receives Approval from China's Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM

DelMar Pharmaceuticals a biopharmaceutical company focused on the development of new cancer therapies today announced that the Human Genetic Resources Administration of China HGRAC has approved the Companys application to…

EventsRead more...

24-26

Jul 2017

World Congress on Nursing Care 2017

Conference Series LLC
Melbourne

25-27

Jul 2017

Supply Chain Operations and Compliance in Pharma

Hanson Wade
Sheraton Philadelphia University City Hotel

TOP ARTICLES

  • 4

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Antimicrobial Stewardship Prioritising Quality Access to Healthcare

    Antimicrobials treatments that kill or inhibit the growth of microorganisms are effective and necessary in medicine However organisms and microbes have increasingly begun to resist antimicrobial agents through evolutionary change and mutations Resistance to antimicrobials creates a difficult path for infectious disease medicine because it becomes harder and harder to treat resistant microbes While…

  • Techno Trends

    FDA Approves Novartis Kisqali® Femara® Co-Pack to treat metastatic breast cancer

    Novartis has announced that its Kisqali Femara CoPack the first and only currently available combination pack with two prescription products in advanced breast cancer has received approval from the US Food and Drug Administration FDA The Kisqali Femara CoPack ribociclib tablets letrozole tablets is used to treat hormone receptorpositive human epidermal growth factor receptor negative HR HER advanced or metastatic…

Editorial Section

  • Strategy

    Failing Data Integrity Audit is not an Option

    The timetomarket of blooming Asian pharmaceutical companies especially from India and China are being slowed by the increasing concerns of global and local regulators over data integrity How can they meet regulators audit expectation on data integrity and provide assurance…

  • Clinical Trails

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Manufacturing

    Added Costs for Added Protections

    The Impact of Implementing Safety Features in Pharmaceutical Packaging and Labelling Serialization Unique Device Identification UDI and aggregation catalyse a paradigm shift for the entire industry and are already impacting the pharmaceutical supply chain In…

  • Expert Talk

    The Asian Healthcare Market

    The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…

TOP